Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

Led by UCD’s Prof Breandán Kennedy, EVEREST will bring together 21 institutions from 11 countries to advance the study of ...

A recent review article highlights how extracellular vesicles (EVs) act as key players in the development of cancer drug resistance. The study explains how EVs, secreted by both cancerous and ...

The abstract will be made available on the publications section of the Capricor website.

Brain disorders like Parkinson's or Alzheimer's Disease start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages could slow or ...

FORT LAUDERDALE, FL / / November 13, 2024 / ZEO ScientifiX, Inc. ('ZEO' or the 'Company') (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced it has partnered with ...